TPO and Wilson disease: This LN–PLT interaction network not only provides a dual-dimensional biomarker system (“structural remodeling-functional compensation”) for predicting advanced hepatic fibrosis in WD but also establishes a theoretical foundation for combinatorial targeting of extracellular metabolism and modulation of PLT function (such as TPO agonists or antifibrotic factor delivery).